# Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

> **NCT06040125** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 80 (estimated)

## Conditions studied

- PROSTATE CANCER
- Metastatic Prostate Cancer
- Metastatic Prostate Carcinoma

## Interventions

- **BEHAVIORAL:** Supervised Circuit Training

## Key facts

- **NCT ID:** NCT06040125
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-08-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06040125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06040125, "Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06040125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*